XML 13 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:      
Loss $ (2,650) $ (2,638) $ (3,535)
Adjustments to the profit or loss items:      
Depreciation and amortization 1 33 164
Cost of share-based payment 24 169 91
Finance expenses, net 13 710 (476)
Impairment of investment in associate 795
Total adjustments to the profit or loss 38 912 574
Working capital adjustments:      
Decrease (increase) in other accounts receivable (137) (557) (519)
Increase (decrease) in trade payables (202) 193 (752)
Decrease in other accounts payable (43) (75)
Working capital (339) (407) (1,346)
Net cash used in operating activities (2,951) (2,133) (4,307)
Cash flows from investing activities:      
Investment in restricted bank deposits (1) 24
Net cash provided by investing activities (1) 24
Cash flows from financing activities:      
Proceeds from issue of share capital and warrants (net of issuance expenses) (Note 4) 7,699 1,441 5,026
Payment of issuance expenses related to previous period (b) 116
Interest paid on lease liability (7)
Repayment of lease liability (26)
Exercise of warrants (Note 4c) 1,085
Repayment of short-term credit (188) (8) (1,410)
Receipt of short-term credit from others, net (26) 1,660
Net cash provided by financing activities 8,596 1,407 5,359
Increase (decrease) in cash and cash equivalents 5,644 (726) 1,076
Cash and cash equivalents at the beginning of the period 1,946 870 870
Cash and cash equivalents at the end of the period 7,590 144 1,946
Investment in associate 742
Exercise of warrants 1,419
Modification of leasing agreement $ 101